Beetroot Juice and Postprandial Vascular Activity
This study has been completed.
Sponsor:
Maastricht University Medical Center
Collaborator:
Top Institute Food and Nutrition
Information provided by (Responsible Party):
Maastricht University Medical Center
ClinicalTrials.gov Identifier:
NCT01559441
First received: March 12, 2012
Last updated: August 27, 2012
Last verified: August 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Increased postprandial lipemia may increase the risk for cardiovascular diseases. An important mechanistic link between lipemia following a high-fat meal and adverse cardiovascular events is lipid-mediated endothelial activation. Therefore, it is important to identify nutrients that can neutralize this acute vascular disturbance.
The investigators hypothesize that beetroot juice, a food rich in inorganic nitrate, could improve vascular activity during the postprandial phase.
| Condition | Intervention |
|---|---|
|
Dyslipidemia |
Dietary Supplement: Beetroot Juice with oral fat load Dietary Supplement: Carbohydrate control drink with oral fat load |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Crossover Assignment Masking: Open Label Primary Purpose: Basic Science |
| Official Title: | The Effects of Beetroot Juice on Postprandial Vascular Activity After a High-fat Meal in Overweight and Slightly Obese Men |
Further study details as provided by Maastricht University Medical Center:
Primary Outcome Measures:
- Vascular activity [ Time Frame: Change from baseline at 3 hours after meal consumption ] [ Designated as safety issue: No ]Flow-mediated dilation (FMD) of the brachial artery
Secondary Outcome Measures:
- Arterial stiffness [ Time Frame: Change from baseline at 3 hours after meal consumption ] [ Designated as safety issue: No ]Pulse wave analysis (PWA) and velocity (PWV)
- Microcirculatory effects [ Time Frame: Change from baseline at 3 hours after meal consumption ] [ Designated as safety issue: No ]Retinal imaging
- Metabolic risk markers related to the metabolic syndrome [ Time Frame: During 4 hours after meal consumption ] [ Designated as safety issue: No ]Changes in biomarkers for low-grade systemic inflammation and endothelial activation.
- Postprandial lipid metabolism [ Time Frame: During 4 hours after meal consumption ] [ Designated as safety issue: No ]
- Postprandial glucose metabolism [ Time Frame: During 4 hours after meal consumption ] [ Designated as safety issue: No ]
| Enrollment: | 20 |
| Study Start Date: | March 2012 |
| Study Completion Date: | August 2012 |
| Primary Completion Date: | August 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: Beetroot juice |
Dietary Supplement: Beetroot Juice with oral fat load
140mL (9.6 mmol nitrate) beetroot juice (Beet It, James White drinks Ltd)
|
| Placebo Comparator: Carbohydrate control drink |
Dietary Supplement: Carbohydrate control drink with oral fat load
140 mL (low-nitrate) carbohydrate control drink
|
Eligibility| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Aged between 18 and 70 years
- Quetelet-index between 28-35 kg/m2
- Mean serum triacylglycerol ≤1.7 mmol/L
- No indication for treatment with cholesterol-lowering drugs according to the Dutch Cholesterol Consensus
- No current smoker
- No diabetic patients or individuals receiving antidiabetic medication
- No familial hypercholesterolemia
- No abuse of drugs
- Less than 21 alcoholic consumptions per week
- Stable body weight (weight gain or loss <3 kg in the past three months)
- No use of medication known to affect serum lipid metabolism
- No severe medical conditions that might interfere with the study, such as high blood pressure, epilepsy, asthma, allergies, chronic obstructive pulmonary disease, inflammatory bowel diseases, auto inflammatory diseases and rheumatoid arthritis
- No active cardiovascular disease like congestive heart failure or recent (<6 months) event (acute myocardial infarction, cerebro vascular accident)
- Willingness to stop the consumption of foods rich in nitrates 3 weeks before the start of the study. Vegetables such as beets, celery, radishes, turnips and spinach are rich in nitrates
- Willingness to give up being a blood donor (or having donated blood) from 8 weeks before the start of the study, during the study and for 4 weeks after completion of the study
- No difficult venipuncture as evidenced during the screening visits
Exclusion Criteria:
- Women
- Quetelet-index between <28 or >35 kg/m2
- Mean serum triacylglycerol ≥1.7 mmol/L
- Indication for treatment with cholesterol-lowering drugs according to the Dutch Cholesterol Consensus
- Current smoker
- Diabetic patients or individuals receiving antidiabetic medication
- Familial hypercholesterolemia
- Abuse of drugs
- More than 21 alcoholic consumptions per week
- Unstable body weight (weight gain or loss >3 kg in the past three months)
- Use of use of medication known to affect serum lipid metabolism
- No severe medical conditions that might interfere with the study, such as high blood pressure, epilepsy, asthma, allergies, chronic obstructive pulmonary disease, inflammatory bowel diseases, auto inflammatory diseases and rheumatoid arthritis
- Active cardiovascular disease like congestive heart failure or recent (<6 months) event (acute myocardial infarction, cerebro vascular accident)
- Use of an investigational product within the previous 1 month
- Not willing to stop the consumption of foods rich in nitrates 3 weeks before the start of the study
- Not willing to give up being a blood donor (or having donated blood) from 8 weeks before the start of the study, during the study or for 4 weeks after completion of the study
- Not or difficult to venipuncture as evidenced during the screening visits
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01559441
Locations
| Netherlands | |
| Maastricht University Medical Center | |
| Maastricht, Netherlands | |
Sponsors and Collaborators
Maastricht University Medical Center
Top Institute Food and Nutrition
Investigators
| Principal Investigator: | Ronald P Mensink, PhD | Maastricht University Medical Center |
More Information
No publications provided
| Responsible Party: | Maastricht University Medical Center |
| ClinicalTrials.gov Identifier: | NCT01559441 History of Changes |
| Other Study ID Numbers: | METC 11-3-085 |
| Study First Received: | March 12, 2012 |
| Last Updated: | August 27, 2012 |
| Health Authority: | Netherlands: The Central Committee on Research Involving Human Subjects (CCMO) |
Keywords provided by Maastricht University Medical Center:
|
beetroot juice nitrate vascular activity postprandial state |
Additional relevant MeSH terms:
|
Dyslipidemias Lipid Metabolism Disorders Metabolic Diseases |
ClinicalTrials.gov processed this record on May 19, 2013